Compare OGN & KMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | KMPR |
|---|---|---|
| Founded | 1923 | 1990 |
| Country | United States | United States |
| Employees | N/A | 7400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2020 | N/A |
| Metric | OGN | KMPR |
|---|---|---|
| Price | $13.31 | $30.65 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $11.40 | ★ $47.67 |
| AVG Volume (30 Days) | ★ 15.2M | 626.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | 0.60% | ★ 3.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | N/A |
| Revenue Next Year | $1.67 | $4.35 |
| P/E Ratio | $24.26 | ★ $14.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $27.74 |
| 52 Week High | $13.44 | $65.32 |
| Indicator | OGN | KMPR |
|---|---|---|
| Relative Strength Index (RSI) | 77.58 | 40.84 |
| Support Level | $8.59 | $29.20 |
| Resistance Level | N/A | $32.01 |
| Average True Range (ATR) | 0.32 | 1.18 |
| MACD | 0.10 | -0.36 |
| Stochastic Oscillator | 97.87 | 41.74 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.